Phase I Clinical Evaluation of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b in Human Adult Volunteers

Since 1989, we have been involved in the development of a vaccine against Haemophilus influenzae type b. The new vaccine is based on the conjugation of synthetic oligosaccharides to tetanus toxoid. Our main goals have been (i) to verify the feasibility of using the synthetic antigen and (ii) to sear...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Toraño, Gilda, Toledo, Maria E., Baly, Alberto, Fernandez-Santana, Violeta, Rodriguez, Francisco, Alvarez, Yunia, Serrano, Teresita, Musachio, Alexis, Hernandez, Ibis, Hardy, Eugenio, Rodríguez, Arlene, Hernandez, Hector, Aguilar, Aristides, Sánchez, Raydel, Diaz, Manuel, Muzio, Verena, Dfana, Jorgelina, Rodríguez, Maria C., Heynngnezz, Lazaro, Verez-Bencomo, Vicente
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2006
Assuntos:
Vaccine Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1563574/
https://ncbi.nlm.nih.gov/pubmed/16960118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00144-06
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares